Bioactive Surface for Hepatocyte Monolayer Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Hepatocyte spheroids in 3D cultures face challenges with poor mass transport of nutrients and oxygen, leading to limited usefulness due to poor adhesion and cell loss, which are not adequately addressed by existing substrates that either cause hepatocyte de-differentiation or result in unstable spheroid formation.
Innovation Solution
A polymer substrate with coupled sugar groups, such as galactose, and peptide groups, like RGD peptides, is used to create a bioactive surface that enhances hepatocyte adhesion and stability, allowing for a 3D hepatocyte monolayer formation with improved liver-specific activities and reduced cell loss.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If hepatocytes are anchored tightly to substrata using conventional extracellular matrix proteins or cell adhesion peptides, then adhesion strength is improved, but hepatocyte de-differentiation occurs and liver-specific activities decrease
Solution Approach 1:
The patent applies local quality by creating a heterogeneous surface with distinct zones: a central non-adhesive zone that prevents de-differentiation and maintains liver-specific functions, surrounded by an adhesive peripheral zone that provides stable anchoring. This spatial differentiation of surface properties allows simultaneous achievement of strong adhesion and functional preservation.
Solution Approach 2:
The substratum is segmented into functionally distinct regions - an inner non-adhesive domain and an outer adhesive domain. This segmentation separates the conflicting requirements of adhesion and functional maintenance into different spatial zones, allowing hepatocytes to adhere peripherally while maintaining central differentiation.
2Reliability
If hepatocytes are anchored loosely to substrata to maintain spheroid formation, then liver-specific activities and tissue-like architecture are improved, but adhesion stability decreases and cell loss increases
Solution Approach 1:
The substratum is segmented into functionally distinct regions - an inner non-adhesive domain and an outer adhesive domain. This segmentation separates the conflicting requirements of adhesion and functional maintenance into different spatial zones, allowing hepatocytes to adhere peripherally while maintaining central differentiation.
Solution Approach 2:
The patent introduces an intermediary non-adhesive zone that mediates between the adhesive substratum and the hepatocyte spheroids. This intermediate region allows spheroids to form and maintain their 3D architecture with high liver-specific activities while the peripheral adhesive zone prevents complete detachment and provides stable anchoring.
3Reliability
If large 3D hepatocyte spheroids are formed to achieve in vivo-like architecture, then tissue-like cell connectivity and liver-specific activities are improved, but mass transport of nutrients and oxygen into the core deteriorates
Solution Approach 1:
The patent transitions from traditional 3D spheroids to a 2.5D configuration where hepatocytes form spheroid-like structures on a planar substratum. This dimensional transition allows the formation of tissue-like 3D architecture with improved cell-cell connectivity while maintaining proximity to the substratum surface, thereby ensuring adequate mass transport of nutrients and oxygen through the cell layer.
4Stability of the object's composition
If 3D hepatocyte spheroids are formed to maintain stable structure, then adhesion stability is improved, but mass transport of metabolites and nutrients deteriorates due to core isolation
Solution Approach 1:
The patent transitions from traditional 3D spheroids to a 2.5D configuration where hepatocytes form spheroid-like structures on a planar substratum. This dimensional transition allows the formation of tissue-like 3D architecture with improved cell-cell connectivity while maintaining proximity to the substratum surface, thereby ensuring adequate mass transport of nutrients and oxygen through the cell layer.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The bioactive surface stabilizes the 3D hepatocyte monolayer, maintaining its structure and function for up to a week, enhancing cell-substratum interactions and liver-specific activities, while avoiding the limitations of traditional 3D spheroids, such as poor mass transport and cell detachment.
Implementation Method 1
A polymer substrate with coupled sugar groups, such as galactose, and peptide groups, like RGD peptides, is used to create a bioactive surface that enhances hepatocyte adhesion and stability
Data Source
AI summary
The invention provides a surface, wherein said surface comprises (i) a polymer substrate and (ii) sugar groups and peptide groups coupled to said substrate suitable for culturing hepatocytes.